nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.194	0.5	CpDpCtD
Nabumetone—osteoarthritis—Prednisone—systemic lupus erythematosus	0.194	0.5	CpDpCtD
Nabumetone—PTGS2—systemic lupus erythematosus	0.181	1	CbGaD
Nabumetone—MPO—Dapsone—systemic lupus erythematosus	0.119	0.396	CbGbCtD
Nabumetone—PTGS2—Dapsone—systemic lupus erythematosus	0.0412	0.137	CbGbCtD
Nabumetone—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0357	0.119	CbGbCtD
Nabumetone—PTGS1—Dapsone—systemic lupus erythematosus	0.0348	0.115	CbGbCtD
Nabumetone—PTGS2—Betamethasone—systemic lupus erythematosus	0.0306	0.102	CbGbCtD
Nabumetone—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0218	0.0724	CbGbCtD
Nabumetone—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0178	0.0591	CbGbCtD
Nabumetone—MPO—endothelium—systemic lupus erythematosus	0.00174	0.0949	CbGeAlD
Nabumetone—CYP1A2—urine—systemic lupus erythematosus	0.00162	0.0884	CbGeAlD
Nabumetone—MPO—blood plasma—systemic lupus erythematosus	0.00154	0.0843	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL23R—systemic lupus erythematosus	0.00147	0.0684	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.00101	0.0468	CbGpPWpGaD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00086	0.0399	CbGpPWpGaD
Nabumetone—CYP1A2—blood plasma—systemic lupus erythematosus	0.000846	0.0462	CbGeAlD
Nabumetone—PTGS1—endothelium—systemic lupus erythematosus	0.000825	0.045	CbGeAlD
Nabumetone—MPO—connective tissue—systemic lupus erythematosus	0.000823	0.0449	CbGeAlD
Nabumetone—PTGS2—endothelium—systemic lupus erythematosus	0.000789	0.043	CbGeAlD
Nabumetone—MPO—skin of body—systemic lupus erythematosus	0.000743	0.0405	CbGeAlD
Nabumetone—PTGS1—blood plasma—systemic lupus erythematosus	0.000733	0.04	CbGeAlD
Nabumetone—PTGS2—blood plasma—systemic lupus erythematosus	0.000701	0.0382	CbGeAlD
Nabumetone—MPO—kidney—systemic lupus erythematosus	0.0007	0.0382	CbGeAlD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000683	0.0317	CbGpPWpGaD
Nabumetone—CYP1A2—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.000636	0.0295	CbGpPWpGaD
Nabumetone—MPO—lymphoid tissue—systemic lupus erythematosus	0.000601	0.0328	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—STAT4—systemic lupus erythematosus	0.000595	0.0276	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL17A—systemic lupus erythematosus	0.000586	0.0272	CbGpPWpGaD
Nabumetone—MPO—bone marrow—systemic lupus erythematosus	0.000548	0.0299	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL12B—systemic lupus erythematosus	0.000545	0.0253	CbGpPWpGaD
Nabumetone—MPO—lung—systemic lupus erythematosus	0.000496	0.0271	CbGeAlD
Nabumetone—MPO—nervous system—systemic lupus erythematosus	0.000459	0.0251	CbGeAlD
Nabumetone—MPO—central nervous system—systemic lupus erythematosus	0.000442	0.0241	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL18—systemic lupus erythematosus	0.0004	0.0186	CbGpPWpGaD
Nabumetone—PTGS1—connective tissue—systemic lupus erythematosus	0.00039	0.0213	CbGeAlD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000376	0.0175	CbGpPWpGaD
Nabumetone—PTGS2—connective tissue—systemic lupus erythematosus	0.000373	0.0204	CbGeAlD
Nabumetone—PTGS1—skin of body—systemic lupus erythematosus	0.000352	0.0192	CbGeAlD
Nabumetone—PTGS2—skin of body—systemic lupus erythematosus	0.000337	0.0184	CbGeAlD
Nabumetone—MPO—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	0.000333	0.0154	CbGpPWpGaD
Nabumetone—PTGS1—kidney—systemic lupus erythematosus	0.000332	0.0181	CbGeAlD
Nabumetone—PTGS2—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.000328	0.0152	CbGpPWpGaD
Nabumetone—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000321	0.159	CbGdCrCtD
Nabumetone—PTGS2—kidney—systemic lupus erythematosus	0.000318	0.0173	CbGeAlD
Nabumetone—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000316	0.156	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000316	0.156	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000309	0.153	CbGdCrCtD
Nabumetone—PTGS2—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.00028	0.013	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—CCL2—systemic lupus erythematosus	0.000276	0.0128	CbGpPWpGaD
Nabumetone—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000273	0.0149	CbGeAlD
Nabumetone—CYP1A2—lung—systemic lupus erythematosus	0.000272	0.0148	CbGeAlD
Nabumetone—PTGS1—tendon—systemic lupus erythematosus	0.000268	0.0146	CbGeAlD
Nabumetone—MPO—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	0.000259	0.012	CbGpPWpGaD
Nabumetone—PTGS2—tendon—systemic lupus erythematosus	0.000256	0.014	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—TYK2—systemic lupus erythematosus	0.00025	0.0116	CbGpPWpGaD
Nabumetone—PTGS2—bone marrow—systemic lupus erythematosus	0.000248	0.0136	CbGeAlD
Nabumetone—MPO—Folate Metabolism—IL4—systemic lupus erythematosus	0.000244	0.0113	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	0.000239	0.0111	CbGpPWpGaD
Nabumetone—PTGS1—lung—systemic lupus erythematosus	0.000235	0.0128	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IFNG—systemic lupus erythematosus	0.000234	0.0109	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000234	0.0108	CbGpPWpGaD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.00023	0.0107	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—CD4—systemic lupus erythematosus	0.000226	0.0105	CbGpPWpGaD
Nabumetone—PTGS2—lung—systemic lupus erythematosus	0.000225	0.0123	CbGeAlD
Nabumetone—PTGS1—nervous system—systemic lupus erythematosus	0.000218	0.0119	CbGeAlD
Nabumetone—MPO—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	0.000213	0.0099	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—CRP—systemic lupus erythematosus	0.000211	0.00979	CbGpPWpGaD
Nabumetone—PTGS1—central nervous system—systemic lupus erythematosus	0.00021	0.0115	CbGeAlD
Nabumetone—PTGS2—nervous system—systemic lupus erythematosus	0.000208	0.0114	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL2—systemic lupus erythematosus	0.000208	0.00967	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000204	0.00946	CbGpPWpGaD
Nabumetone—PTGS2—central nervous system—systemic lupus erythematosus	0.000201	0.0109	CbGeAlD
Nabumetone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.0002	0.00929	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—ALB—systemic lupus erythematosus	0.000199	0.00922	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—F2—systemic lupus erythematosus	0.000195	0.00904	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000194	0.0958	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000191	0.0942	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000191	0.0942	CbGdCrCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.00019	0.00883	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000186	0.0921	CbGdCrCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000185	0.00861	CbGpPWpGaD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000183	0.00848	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	0.000181	0.00842	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—CCL2—systemic lupus erythematosus	0.000173	0.00805	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000167	0.00778	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—ALB—systemic lupus erythematosus	0.000162	0.0075	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	0.000157	0.0073	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	0.000157	0.00728	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000155	0.00718	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	0.000153	0.00711	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—TNF—systemic lupus erythematosus	0.000152	0.00704	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IFNG—systemic lupus erythematosus	0.000147	0.00685	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	0.000146	0.00679	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	0.00014	0.00651	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	0.000138	0.0064	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.000132	0.00612	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL2—systemic lupus erythematosus	0.000131	0.00608	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000131	0.00607	CbGpPWpGaD
Nabumetone—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	0.00013	0.00603	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	0.000128	0.00596	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL6—systemic lupus erythematosus	0.000122	0.00568	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	0.000122	0.00566	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—CD4—systemic lupus erythematosus	0.000117	0.00545	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	0.000117	0.00545	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	0.000117	0.00544	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—PTGS2—systemic lupus erythematosus	0.000117	0.00541	CbGpPWpGaD
Nabumetone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	0.000112	0.00522	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	0.000112	0.00522	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	0.00011	0.00513	CbGpPWpGaD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000109	0.00505	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	0.000108	0.00502	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.000106	0.00491	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000102	0.00473	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	0.000102	0.00473	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	0.000102	0.00472	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	9.9e-05	0.0046	CbGpPWpGaD
Nabumetone—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	9.8e-05	0.00455	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—EP300—systemic lupus erythematosus	9.7e-05	0.0045	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	9.66e-05	0.00448	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—TNF—systemic lupus erythematosus	9.54e-05	0.00443	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	9.47e-05	0.0044	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	9.46e-05	0.00439	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	9.25e-05	0.0043	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	9.07e-05	0.00421	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	8.54e-05	0.00396	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	8.42e-05	0.00391	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	8.4e-05	0.0039	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	8.28e-05	0.00385	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	8.22e-05	0.00382	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	8.06e-05	0.00374	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	7.97e-05	0.0037	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL6—systemic lupus erythematosus	7.7e-05	0.00358	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	7.58e-05	0.00352	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	7.42e-05	0.00344	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	7.29e-05	0.00339	CbGpPWpGaD
Nabumetone—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	7.22e-05	0.00335	CbGpPWpGaD
Nabumetone—Vertigo—Betamethasone—systemic lupus erythematosus	7.05e-05	0.000801	CcSEcCtD
Nabumetone—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	7.05e-05	0.0008	CcSEcCtD
Nabumetone—Syncope—Betamethasone—systemic lupus erythematosus	7.04e-05	0.000799	CcSEcCtD
Nabumetone—Syncope—Dexamethasone—systemic lupus erythematosus	7.04e-05	0.000799	CcSEcCtD
Nabumetone—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	7.04e-05	0.000799	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	7.03e-05	0.00326	CbGpPWpGaD
Nabumetone—Arrhythmia—Prednisone—systemic lupus erythematosus	7.02e-05	0.000797	CcSEcCtD
Nabumetone—Haematuria—Methotrexate—systemic lupus erythematosus	6.97e-05	0.000792	CcSEcCtD
Nabumetone—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	6.95e-05	0.00079	CcSEcCtD
Nabumetone—Vomiting—Leflunomide—systemic lupus erythematosus	6.95e-05	0.000789	CcSEcCtD
Nabumetone—Shock—Triamcinolone—systemic lupus erythematosus	6.95e-05	0.000789	CcSEcCtD
Nabumetone—Insomnia—Prednisolone—systemic lupus erythematosus	6.95e-05	0.000789	CcSEcCtD
Nabumetone—Alopecia—Prednisone—systemic lupus erythematosus	6.94e-05	0.000788	CcSEcCtD
Nabumetone—Shock—Methylprednisolone—systemic lupus erythematosus	6.93e-05	0.000787	CcSEcCtD
Nabumetone—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	6.9e-05	0.000783	CcSEcCtD
Nabumetone—Loss of consciousness—Betamethasone—systemic lupus erythematosus	6.9e-05	0.000783	CcSEcCtD
Nabumetone—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	6.9e-05	0.000783	CcSEcCtD
Nabumetone—Paraesthesia—Prednisolone—systemic lupus erythematosus	6.9e-05	0.000783	CcSEcCtD
Nabumetone—Rash—Leflunomide—systemic lupus erythematosus	6.89e-05	0.000783	CcSEcCtD
Nabumetone—Dermatitis—Leflunomide—systemic lupus erythematosus	6.89e-05	0.000782	CcSEcCtD
Nabumetone—Nausea—Azathioprine—systemic lupus erythematosus	6.88e-05	0.000781	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	6.85e-05	0.00318	CbGpPWpGaD
Nabumetone—Headache—Leflunomide—systemic lupus erythematosus	6.85e-05	0.000778	CcSEcCtD
Nabumetone—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	6.83e-05	0.000775	CcSEcCtD
Nabumetone—Agranulocytosis—Methotrexate—systemic lupus erythematosus	6.82e-05	0.000775	CcSEcCtD
Nabumetone—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	6.81e-05	0.000773	CcSEcCtD
Nabumetone—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	6.78e-05	0.00077	CcSEcCtD
Nabumetone—Insomnia—Hydrocortisone—systemic lupus erythematosus	6.78e-05	0.00077	CcSEcCtD
Nabumetone—Hypertension—Betamethasone—systemic lupus erythematosus	6.78e-05	0.00077	CcSEcCtD
Nabumetone—Hypertension—Dexamethasone—systemic lupus erythematosus	6.78e-05	0.00077	CcSEcCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	6.78e-05	0.00315	CbGpPWpGaD
Nabumetone—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	6.73e-05	0.000765	CcSEcCtD
Nabumetone—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.73e-05	0.000764	CcSEcCtD
Nabumetone—Urticaria—Cyclosporine—systemic lupus erythematosus	6.7e-05	0.000761	CcSEcCtD
Nabumetone—Abdominal pain—Cyclosporine—systemic lupus erythematosus	6.67e-05	0.000757	CcSEcCtD
Nabumetone—Body temperature increased—Cyclosporine—systemic lupus erythematosus	6.67e-05	0.000757	CcSEcCtD
Nabumetone—Anxiety—Dexamethasone—systemic lupus erythematosus	6.66e-05	0.000756	CcSEcCtD
Nabumetone—Anxiety—Betamethasone—systemic lupus erythematosus	6.66e-05	0.000756	CcSEcCtD
Nabumetone—Discomfort—Betamethasone—systemic lupus erythematosus	6.6e-05	0.00075	CcSEcCtD
Nabumetone—Discomfort—Dexamethasone—systemic lupus erythematosus	6.6e-05	0.00075	CcSEcCtD
Nabumetone—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	6.6e-05	0.00075	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—systemic lupus erythematosus	6.6e-05	0.000749	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—systemic lupus erythematosus	6.56e-05	0.000745	CcSEcCtD
Nabumetone—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	6.54e-05	0.000742	CcSEcCtD
Nabumetone—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	6.52e-05	0.00074	CcSEcCtD
Nabumetone—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	6.51e-05	0.000739	CcSEcCtD
Nabumetone—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.51e-05	0.000739	CcSEcCtD
Nabumetone—Nausea—Leflunomide—systemic lupus erythematosus	6.5e-05	0.000737	CcSEcCtD
Nabumetone—Fatigue—Hydrocortisone—systemic lupus erythematosus	6.47e-05	0.000734	CcSEcCtD
Nabumetone—Oedema—Dexamethasone—systemic lupus erythematosus	6.41e-05	0.000727	CcSEcCtD
Nabumetone—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	6.41e-05	0.000727	CcSEcCtD
Nabumetone—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	6.41e-05	0.000727	CcSEcCtD
Nabumetone—Oedema—Betamethasone—systemic lupus erythematosus	6.41e-05	0.000727	CcSEcCtD
Nabumetone—Insomnia—Triamcinolone—systemic lupus erythematosus	6.39e-05	0.000725	CcSEcCtD
Nabumetone—Insomnia—Methylprednisolone—systemic lupus erythematosus	6.37e-05	0.000724	CcSEcCtD
Nabumetone—Ill-defined disorder—Prednisone—systemic lupus erythematosus	6.34e-05	0.00072	CcSEcCtD
Nabumetone—Paraesthesia—Triamcinolone—systemic lupus erythematosus	6.34e-05	0.00072	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	6.33e-05	0.000718	CcSEcCtD
Nabumetone—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	6.33e-05	0.000718	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—systemic lupus erythematosus	6.33e-05	0.000718	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	6.33e-05	0.00294	CbGpPWpGaD
Nabumetone—Anaemia—Prednisone—systemic lupus erythematosus	6.32e-05	0.000717	CcSEcCtD
Nabumetone—Shock—Betamethasone—systemic lupus erythematosus	6.3e-05	0.000716	CcSEcCtD
Nabumetone—Shock—Dexamethasone—systemic lupus erythematosus	6.3e-05	0.000716	CcSEcCtD
Nabumetone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.3e-05	0.000715	CcSEcCtD
Nabumetone—Agitation—Prednisone—systemic lupus erythematosus	6.28e-05	0.000713	CcSEcCtD
Nabumetone—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.27e-05	0.000712	CcSEcCtD
Nabumetone—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.27e-05	0.000712	CcSEcCtD
Nabumetone—Angioedema—Prednisone—systemic lupus erythematosus	6.25e-05	0.000709	CcSEcCtD
Nabumetone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	6.22e-05	0.000706	CcSEcCtD
Nabumetone—Dyspepsia—Triamcinolone—systemic lupus erythematosus	6.22e-05	0.000706	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—systemic lupus erythematosus	6.21e-05	0.000705	CcSEcCtD
Nabumetone—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	6.2e-05	0.000704	CcSEcCtD
Nabumetone—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	6.19e-05	0.000703	CcSEcCtD
Nabumetone—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	6.19e-05	0.000703	CcSEcCtD
Nabumetone—Naproxen—PTGS2—systemic lupus erythematosus	6.19e-05	0.529	CrCbGaD
Nabumetone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	6.18e-05	0.000702	CcSEcCtD
Nabumetone—Malaise—Prednisone—systemic lupus erythematosus	6.17e-05	0.0007	CcSEcCtD
Nabumetone—Vertigo—Prednisone—systemic lupus erythematosus	6.14e-05	0.000697	CcSEcCtD
Nabumetone—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	6.13e-05	0.000696	CcSEcCtD
Nabumetone—Syncope—Prednisone—systemic lupus erythematosus	6.13e-05	0.000696	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—systemic lupus erythematosus	6.12e-05	0.000695	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	6.12e-05	0.00284	CbGpPWpGaD
Nabumetone—Anorexia—Dexamethasone—systemic lupus erythematosus	6.11e-05	0.000693	CcSEcCtD
Nabumetone—Anorexia—Betamethasone—systemic lupus erythematosus	6.11e-05	0.000693	CcSEcCtD
Nabumetone—Urticaria—Prednisolone—systemic lupus erythematosus	6.1e-05	0.000693	CcSEcCtD
Nabumetone—Fatigue—Triamcinolone—systemic lupus erythematosus	6.09e-05	0.000691	CcSEcCtD
Nabumetone—Fatigue—Methylprednisolone—systemic lupus erythematosus	6.08e-05	0.00069	CcSEcCtD
Nabumetone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.07e-05	0.000689	CcSEcCtD
Nabumetone—Asthenia—Cyclosporine—systemic lupus erythematosus	6.05e-05	0.000687	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisone—systemic lupus erythematosus	6.01e-05	0.000682	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	5.98e-05	0.00278	CbGpPWpGaD
Nabumetone—Pruritus—Cyclosporine—systemic lupus erythematosus	5.97e-05	0.000678	CcSEcCtD
Nabumetone—Urticaria—Hydrocortisone—systemic lupus erythematosus	5.96e-05	0.000676	CcSEcCtD
Nabumetone—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.93e-05	0.000673	CcSEcCtD
Nabumetone—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.93e-05	0.000673	CcSEcCtD
Nabumetone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.91e-05	0.000671	CcSEcCtD
Nabumetone—Hypertension—Prednisone—systemic lupus erythematosus	5.9e-05	0.00067	CcSEcCtD
Nabumetone—Chills—Methotrexate—systemic lupus erythematosus	5.89e-05	0.000669	CcSEcCtD
Nabumetone—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.82e-05	0.000661	CcSEcCtD
Nabumetone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	5.82e-05	0.000661	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	5.81e-05	0.0027	CbGpPWpGaD
Nabumetone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	5.81e-05	0.000659	CcSEcCtD
Nabumetone—Anxiety—Prednisone—systemic lupus erythematosus	5.8e-05	0.000659	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—systemic lupus erythematosus	5.8e-05	0.000659	CcSEcCtD
Nabumetone—Insomnia—Dexamethasone—systemic lupus erythematosus	5.8e-05	0.000658	CcSEcCtD
Nabumetone—Insomnia—Betamethasone—systemic lupus erythematosus	5.8e-05	0.000658	CcSEcCtD
Nabumetone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.77e-05	0.000656	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.76e-05	0.000654	CcSEcCtD
Nabumetone—Paraesthesia—Dexamethasone—systemic lupus erythematosus	5.75e-05	0.000653	CcSEcCtD
Nabumetone—Paraesthesia—Betamethasone—systemic lupus erythematosus	5.75e-05	0.000653	CcSEcCtD
Nabumetone—Discomfort—Prednisone—systemic lupus erythematosus	5.75e-05	0.000653	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	5.66e-05	0.000642	CcSEcCtD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.65e-05	0.00262	CbGpPWpGaD
Nabumetone—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.64e-05	0.00064	CcSEcCtD
Nabumetone—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.64e-05	0.00064	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	5.64e-05	0.00262	CbGpPWpGaD
Nabumetone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.63e-05	0.000639	CcSEcCtD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.62e-05	0.00261	CbGpPWpGaD
Nabumetone—Urticaria—Triamcinolone—systemic lupus erythematosus	5.61e-05	0.000637	CcSEcCtD
Nabumetone—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.6e-05	0.000635	CcSEcCtD
Nabumetone—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.58e-05	0.000634	CcSEcCtD
Nabumetone—Dizziness—Cyclosporine—systemic lupus erythematosus	5.58e-05	0.000634	CcSEcCtD
Nabumetone—Oedema—Prednisone—systemic lupus erythematosus	5.58e-05	0.000634	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.58e-05	0.000634	CcSEcCtD
Nabumetone—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.57e-05	0.000632	CcSEcCtD
Nabumetone—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.57e-05	0.000632	CcSEcCtD
Nabumetone—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.57e-05	0.000632	CcSEcCtD
Nabumetone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.53e-05	0.000627	CcSEcCtD
Nabumetone—Fatigue—Betamethasone—systemic lupus erythematosus	5.52e-05	0.000627	CcSEcCtD
Nabumetone—Fatigue—Dexamethasone—systemic lupus erythematosus	5.52e-05	0.000627	CcSEcCtD
Nabumetone—Naproxen—ALB—systemic lupus erythematosus	5.51e-05	0.471	CrCbGaD
Nabumetone—Shock—Prednisone—systemic lupus erythematosus	5.49e-05	0.000623	CcSEcCtD
Nabumetone—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.44e-05	0.000618	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	5.44e-05	0.00253	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	5.41e-05	0.00251	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5.39e-05	0.000612	CcSEcCtD
Nabumetone—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.38e-05	0.000611	CcSEcCtD
Nabumetone—Vomiting—Cyclosporine—systemic lupus erythematosus	5.37e-05	0.000609	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.36e-05	0.00249	CbGpPWpGaD
Nabumetone—Rash—Cyclosporine—systemic lupus erythematosus	5.32e-05	0.000604	CcSEcCtD
Nabumetone—Anorexia—Prednisone—systemic lupus erythematosus	5.32e-05	0.000604	CcSEcCtD
Nabumetone—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.32e-05	0.000604	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	5.32e-05	0.00247	CbGpPWpGaD
Nabumetone—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.31e-05	0.000602	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	5.3e-05	0.000602	CcSEcCtD
Nabumetone—Headache—Cyclosporine—systemic lupus erythematosus	5.29e-05	0.0006	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—systemic lupus erythematosus	5.28e-05	0.0006	CcSEcCtD
Nabumetone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.28e-05	0.000599	CcSEcCtD
Nabumetone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.28e-05	0.000599	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	5.25e-05	0.00244	CbGpPWpGaD
Nabumetone—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.24e-05	0.000595	CcSEcCtD
Nabumetone—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.24e-05	0.000595	CcSEcCtD
Nabumetone—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.23e-05	0.000594	CcSEcCtD
Nabumetone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.2e-05	0.000591	CcSEcCtD
Nabumetone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.19e-05	0.000589	CcSEcCtD
Nabumetone—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.19e-05	0.000589	CcSEcCtD
Nabumetone—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.19e-05	0.000589	CcSEcCtD
Nabumetone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.16e-05	0.000585	CcSEcCtD
Nabumetone—Malaise—Methotrexate—systemic lupus erythematosus	5.15e-05	0.000585	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—systemic lupus erythematosus	5.13e-05	0.000583	CcSEcCtD
Nabumetone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.13e-05	0.000583	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—systemic lupus erythematosus	5.12e-05	0.000581	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.1e-05	0.00237	CbGpPWpGaD
Nabumetone—Urticaria—Betamethasone—systemic lupus erythematosus	5.09e-05	0.000578	CcSEcCtD
Nabumetone—Urticaria—Dexamethasone—systemic lupus erythematosus	5.09e-05	0.000578	CcSEcCtD
Nabumetone—Dizziness—Prednisolone—systemic lupus erythematosus	5.08e-05	0.000577	CcSEcCtD
Nabumetone—Asthenia—Triamcinolone—systemic lupus erythematosus	5.07e-05	0.000575	CcSEcCtD
Nabumetone—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.07e-05	0.000575	CcSEcCtD
Nabumetone—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.07e-05	0.000575	CcSEcCtD
Nabumetone—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.07e-05	0.000575	CcSEcCtD
Nabumetone—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.07e-05	0.000575	CcSEcCtD
Nabumetone—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.06e-05	0.000574	CcSEcCtD
Nabumetone—Insomnia—Prednisone—systemic lupus erythematosus	5.05e-05	0.000573	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	5.02e-05	0.00233	CbGpPWpGaD
Nabumetone—Nausea—Cyclosporine—systemic lupus erythematosus	5.01e-05	0.000569	CcSEcCtD
Nabumetone—Paraesthesia—Prednisone—systemic lupus erythematosus	5.01e-05	0.000569	CcSEcCtD
Nabumetone—Pruritus—Triamcinolone—systemic lupus erythematosus	5e-05	0.000567	CcSEcCtD
Nabumetone—Cough—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000566	CcSEcCtD
Nabumetone—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.99e-05	0.000566	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	4.98e-05	0.00231	CbGpPWpGaD
Nabumetone—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.96e-05	0.000563	CcSEcCtD
Nabumetone—Dyspepsia—Prednisone—systemic lupus erythematosus	4.91e-05	0.000558	CcSEcCtD
Nabumetone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.89e-05	0.000555	CcSEcCtD
Nabumetone—Decreased appetite—Prednisone—systemic lupus erythematosus	4.85e-05	0.000551	CcSEcCtD
Nabumetone—Rash—Prednisolone—systemic lupus erythematosus	4.84e-05	0.00055	CcSEcCtD
Nabumetone—Dermatitis—Prednisolone—systemic lupus erythematosus	4.84e-05	0.000549	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	4.83e-05	0.00224	CbGpPWpGaD
Nabumetone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.82e-05	0.000547	CcSEcCtD
Nabumetone—Fatigue—Prednisone—systemic lupus erythematosus	4.81e-05	0.000546	CcSEcCtD
Nabumetone—Headache—Prednisolone—systemic lupus erythematosus	4.81e-05	0.000546	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000546	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	4.79e-05	0.00223	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.78e-05	0.00222	CbGpPWpGaD
Nabumetone—Constipation—Prednisone—systemic lupus erythematosus	4.77e-05	0.000542	CcSEcCtD
Nabumetone—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.77e-05	0.000541	CcSEcCtD
Nabumetone—Rash—Hydrocortisone—systemic lupus erythematosus	4.73e-05	0.000537	CcSEcCtD
Nabumetone—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.72e-05	0.000536	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000534	CcSEcCtD
Nabumetone—Headache—Hydrocortisone—systemic lupus erythematosus	4.7e-05	0.000533	CcSEcCtD
Nabumetone—Dizziness—Triamcinolone—systemic lupus erythematosus	4.67e-05	0.00053	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.66e-05	0.000529	CcSEcCtD
Nabumetone—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.66e-05	0.000529	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.6e-05	0.000522	CcSEcCtD
Nabumetone—Asthenia—Dexamethasone—systemic lupus erythematosus	4.6e-05	0.000522	CcSEcCtD
Nabumetone—Asthenia—Betamethasone—systemic lupus erythematosus	4.6e-05	0.000522	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	4.6e-05	0.00213	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.58e-05	0.00213	CbGpPWpGaD
Nabumetone—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.57e-05	0.000518	CcSEcCtD
Nabumetone—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.56e-05	0.000518	CcSEcCtD
Nabumetone—Nausea—Prednisolone—systemic lupus erythematosus	4.56e-05	0.000518	CcSEcCtD
Nabumetone—Pruritus—Dexamethasone—systemic lupus erythematosus	4.53e-05	0.000515	CcSEcCtD
Nabumetone—Pruritus—Betamethasone—systemic lupus erythematosus	4.53e-05	0.000515	CcSEcCtD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	4.51e-05	0.00209	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000512	CcSEcCtD
Nabumetone—Vomiting—Triamcinolone—systemic lupus erythematosus	4.49e-05	0.00051	CcSEcCtD
Nabumetone—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.48e-05	0.000509	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	4.48e-05	0.00208	CbGpPWpGaD
Nabumetone—Nausea—Hydrocortisone—systemic lupus erythematosus	4.45e-05	0.000506	CcSEcCtD
Nabumetone—Rash—Triamcinolone—systemic lupus erythematosus	4.45e-05	0.000506	CcSEcCtD
Nabumetone—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.45e-05	0.000505	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—systemic lupus erythematosus	4.45e-05	0.000505	CcSEcCtD
Nabumetone—Rash—Methylprednisolone—systemic lupus erythematosus	4.44e-05	0.000504	CcSEcCtD
Nabumetone—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.44e-05	0.000504	CcSEcCtD
Nabumetone—Urticaria—Prednisone—systemic lupus erythematosus	4.43e-05	0.000503	CcSEcCtD
Nabumetone—Headache—Triamcinolone—systemic lupus erythematosus	4.42e-05	0.000502	CcSEcCtD
Nabumetone—Headache—Methylprednisolone—systemic lupus erythematosus	4.41e-05	0.000501	CcSEcCtD
Nabumetone—Abdominal pain—Prednisone—systemic lupus erythematosus	4.41e-05	0.000501	CcSEcCtD
Nabumetone—Body temperature increased—Prednisone—systemic lupus erythematosus	4.41e-05	0.000501	CcSEcCtD
Nabumetone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.38e-05	0.000498	CcSEcCtD
Nabumetone—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.38e-05	0.000498	CcSEcCtD
Nabumetone—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	4.34e-05	0.00201	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.28e-05	0.00199	CbGpPWpGaD
Nabumetone—Dizziness—Betamethasone—systemic lupus erythematosus	4.24e-05	0.000481	CcSEcCtD
Nabumetone—Dizziness—Dexamethasone—systemic lupus erythematosus	4.24e-05	0.000481	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—systemic lupus erythematosus	4.22e-05	0.000479	CcSEcCtD
Nabumetone—Nausea—Triamcinolone—systemic lupus erythematosus	4.19e-05	0.000476	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.19e-05	0.000475	CcSEcCtD
Nabumetone—Nausea—Methylprednisolone—systemic lupus erythematosus	4.19e-05	0.000475	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	4.17e-05	0.00194	CbGpPWpGaD
Nabumetone—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000472	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—systemic lupus erythematosus	4.15e-05	0.000471	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.14e-05	0.00192	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	4.13e-05	0.00192	CbGpPWpGaD
Nabumetone—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.11e-05	0.000467	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000466	CcSEcCtD
Nabumetone—Vomiting—Betamethasone—systemic lupus erythematosus	4.07e-05	0.000463	CcSEcCtD
Nabumetone—Vomiting—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.000463	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.05e-05	0.00046	CcSEcCtD
Nabumetone—Rash—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.000459	CcSEcCtD
Nabumetone—Rash—Betamethasone—systemic lupus erythematosus	4.04e-05	0.000459	CcSEcCtD
Nabumetone—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.000458	CcSEcCtD
Nabumetone—Dermatitis—Betamethasone—systemic lupus erythematosus	4.04e-05	0.000458	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—systemic lupus erythematosus	4.02e-05	0.000456	CcSEcCtD
Nabumetone—Headache—Betamethasone—systemic lupus erythematosus	4.01e-05	0.000456	CcSEcCtD
Nabumetone—Headache—Dexamethasone—systemic lupus erythematosus	4.01e-05	0.000456	CcSEcCtD
Nabumetone—Asthenia—Prednisone—systemic lupus erythematosus	4e-05	0.000455	CcSEcCtD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.95e-05	0.00184	CbGpPWpGaD
Nabumetone—Pruritus—Prednisone—systemic lupus erythematosus	3.95e-05	0.000448	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	3.87e-05	0.0018	CbGpPWpGaD
Nabumetone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000436	CcSEcCtD
Nabumetone—Diarrhoea—Prednisone—systemic lupus erythematosus	3.82e-05	0.000433	CcSEcCtD
Nabumetone—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	3.82e-05	0.00177	CbGpPWpGaD
Nabumetone—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.81e-05	0.000433	CcSEcCtD
Nabumetone—Nausea—Betamethasone—systemic lupus erythematosus	3.81e-05	0.000432	CcSEcCtD
Nabumetone—Nausea—Dexamethasone—systemic lupus erythematosus	3.81e-05	0.000432	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	3.81e-05	0.00177	CbGpPWpGaD
Nabumetone—Urticaria—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000421	CcSEcCtD
Nabumetone—Dizziness—Prednisone—systemic lupus erythematosus	3.69e-05	0.000419	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000419	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000419	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	3.62e-05	0.00168	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	3.59e-05	0.00167	CbGpPWpGaD
Nabumetone—Vomiting—Prednisone—systemic lupus erythematosus	3.55e-05	0.000403	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	3.54e-05	0.00164	CbGpPWpGaD
Nabumetone—Rash—Prednisone—systemic lupus erythematosus	3.52e-05	0.000399	CcSEcCtD
Nabumetone—Dermatitis—Prednisone—systemic lupus erythematosus	3.52e-05	0.000399	CcSEcCtD
Nabumetone—Headache—Prednisone—systemic lupus erythematosus	3.5e-05	0.000397	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	3.47e-05	0.00161	CbGpPWpGaD
Nabumetone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.44e-05	0.00039	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—systemic lupus erythematosus	3.35e-05	0.00038	CcSEcCtD
Nabumetone—Nausea—Prednisone—systemic lupus erythematosus	3.31e-05	0.000376	CcSEcCtD
Nabumetone—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	3.31e-05	0.00154	CbGpPWpGaD
Nabumetone—Pruritus—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000375	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.29e-05	0.00153	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.29e-05	0.00153	CbGpPWpGaD
Nabumetone—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.25e-05	0.00151	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.24e-05	0.0015	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.22e-05	0.00149	CbGpPWpGaD
Nabumetone—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000362	CcSEcCtD
Nabumetone—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	3.15e-05	0.00146	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.12e-05	0.00145	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	3.1e-05	0.00144	CbGpPWpGaD
Nabumetone—Dizziness—Methotrexate—systemic lupus erythematosus	3.08e-05	0.00035	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.03e-05	0.00141	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	3.01e-05	0.0014	CbGpPWpGaD
Nabumetone—Vomiting—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000337	CcSEcCtD
Nabumetone—Rash—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000334	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000334	CcSEcCtD
Nabumetone—Headache—Methotrexate—systemic lupus erythematosus	2.92e-05	0.000332	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.89e-05	0.00134	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.89e-05	0.00134	CbGpPWpGaD
Nabumetone—Nausea—Methotrexate—systemic lupus erythematosus	2.77e-05	0.000314	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	2.73e-05	0.00127	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.73e-05	0.00127	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	2.67e-05	0.00124	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	2.53e-05	0.00118	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.51e-05	0.00116	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.5e-05	0.00116	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.46e-05	0.00114	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.43e-05	0.00113	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.34e-05	0.00109	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.34e-05	0.00109	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	2.09e-05	0.000969	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.08e-05	0.000965	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.99e-05	0.000923	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.95e-05	0.000905	CbGpPWpGaD
Nabumetone—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.94e-05	0.000902	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.86e-05	0.000863	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.72e-05	0.000797	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	1.65e-05	0.000767	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.65e-05	0.000766	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.63e-05	0.000758	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	1.57e-05	0.00073	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.55e-05	0.000718	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	1.43e-05	0.000665	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.42e-05	0.000659	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CSK—systemic lupus erythematosus	1.4e-05	0.000648	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.33e-05	0.000615	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.31e-05	0.000609	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD247—systemic lupus erythematosus	1.31e-05	0.000609	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.31e-05	0.000609	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.28e-05	0.000593	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.18e-05	0.000548	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.04e-05	0.000484	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.03e-05	0.000479	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JUNB—systemic lupus erythematosus	1e-05	0.000465	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.37e-06	0.000435	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.34e-06	0.000434	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	9.26e-06	0.00043	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRL—systemic lupus erythematosus	9.23e-06	0.000428	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.59e-06	0.000399	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	7.42e-06	0.000345	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JAK1—systemic lupus erythematosus	7.38e-06	0.000343	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	7.35e-06	0.000341	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CCR5—systemic lupus erythematosus	6.99e-06	0.000325	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.82e-06	0.000317	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.9e-06	0.000274	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	5.85e-06	0.000271	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD80—systemic lupus erythematosus	5.75e-06	0.000267	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.3e-06	0.000246	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—systemic lupus erythematosus	5.26e-06	0.000244	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	5.03e-06	0.000233	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TYK2—systemic lupus erythematosus	4.86e-06	0.000225	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—systemic lupus erythematosus	4.77e-06	0.000221	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	4.64e-06	0.000215	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.64e-06	0.000215	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	4.6e-06	0.000214	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—systemic lupus erythematosus	4.39e-06	0.000204	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—systemic lupus erythematosus	4.17e-06	0.000194	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	4.16e-06	0.000193	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	4.13e-06	0.000192	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	3.99e-06	0.000185	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.86e-06	0.000179	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—EP300—systemic lupus erythematosus	3.82e-06	0.000178	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	3.81e-06	0.000177	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EP300—systemic lupus erythematosus	3.63e-06	0.000168	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—systemic lupus erythematosus	3.15e-06	0.000146	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—EP300—systemic lupus erythematosus	3.04e-06	0.000141	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.63e-06	0.000122	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—systemic lupus erythematosus	2.37e-06	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.36e-06	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.26e-06	0.000105	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.07e-06	9.59e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.72e-06	7.98e-05	CbGpPWpGaD
